<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Cholestyramine</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01432</strong></td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>Cholestyramine or colestyramine is a bile acid sequestrant. Bile acid sequestrants are polymeric compounds which serve as ion exchange resins. Cholestyramine resin is quite hydrophilic, but insoluble in water.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01432/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01432/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01432.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01432.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01432.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01432.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01432.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01432">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Cholestyramine resin</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Colestyramine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Cholybar</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Locholest</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Locholest light</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Prevalite</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Questran</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Questran Light</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/hypolipidemic-agents">Hypolipidemic Agents</a></li>
<li><a href="/mesh/cholesterol-absorption-inhibitors">Cholesterol Absorption Inhibitors</a></li></ul></td></tr><tr><th>CAS number</th><td>11041-12-6</td></tr><tr><th>Weight</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Chemical Formula</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>InChI Key</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>InChI</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>IUPAC Name</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SMILES</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Superclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Class</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Subclass</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Direct parent</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Alternative parents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Substituents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Classification description</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>Indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. Also for the relief of pruritus associated with partial biliary obstruction.</td></tr><tr><th>Pharmacodynamics</th><td>Cholesterol is probably the sole precursor of bile acids. During normal digestion, bile acids are secreted into the intestines. A major portion of the bile acids is absorbed from the intestinal tract and returned to the liver via the enterohepatic circulation. Only very small amounts of bile acids are found in normal serum. Cholestyramine resin adsorbs and combines with the bile acids in the intestine to form an insoluble complex which is excreted in the feces. This results in a partial removal of bile acids from the enterohepatic circulation by preventing their absorption.</td></tr><tr><th>Mechanism of action</th><td>Cholestyramine binds bile in the gastrointestinal tract to prevent its reabsorption. The resin is a strong anion exchange resin, which means that it can exchange its chloride anions with anionic bile acids in the gastrointestinal tract and bind them strongly in the resin matrix. The functional group of the anion exchange resin is a quaternary ammonium group attached to an inert styrene-divinylbenzene copolymer.</td></tr><tr><th>Absorption</th><td>Not absorbed from the gastrointestinal tract following oral administration.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Bile acids</p></td></tr><tr><th>Route of elimination</th><td>Cholestyramine resin adsorbs and combines with the bile acids in the intestine to form an insoluble complex which is excreted in the feces.</td></tr><tr><th>Half life</th><td>6 minutes</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>Overdose may result in blockage of intestine or stomach.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
        <td><span class="wishart wishart-not-available">Not Available</span></td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          <span class="wishart wishart-not-available">Not Available</span> 
        </td>
        <td>
            <span class="wishart wishart-not-available">Not Available</span>
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Parke davis div warner lambert co</li>
<li>Ivax pharmaceuticals inc sub teva pharmaceuticals usa</li>
<li>Par pharmaceutical inc</li>
<li>Sandoz inc</li>
<li>Teva pharmaceuticals usa inc</li>
<li>Teva pharmaceuticals usa</li>
<li>Upsher smith laboratories inc</li>
<li>Bristol myers co</li>
<li>Apothecon inc div bristol myers squibb</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li><a href="http://www.bms.com">Bristol-Myers Squibb Co.</a></li>
<li><a href="http://www.catalent.com">Catalent Pharma Solutions</a></li>
<li>Eon Labs</li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li><a href="http://www.meadjohnson.com">Mead Johnson and Co.</a></li>
<li><a href="http://www.medisca.com">Medisca Inc.</a></li>
<li>Novopharm Ltd.</li>
<li><a href="http://www.parpharm.com">Par Pharmaceuticals</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.upsher-smith.com">Upsher Smith Laboratories</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Powder</td><td>Oral</td><td></td></tr><tr><td>Powder, for solution</td><td>Oral</td><td></td></tr><tr><td>Powder, for suspension</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Questran Light 4 gm/dose Powder 210 gm Can</td><td>116.3USD</td><td>can</td></tr><tr><td>Questran 4 gm/dose Powder 378 gm Can</td><td>115.62USD</td><td>can</td></tr><tr><td>Questran Light 4 gm/dose Powder 268 gm Can</td><td>102.35USD</td><td>can</td></tr><tr><td>Cholestyramine 4 gm/dose Powder 378 gm Can</td><td>57.99USD</td><td>can</td></tr><tr><td>Cholestyramine Light 4 gm/dose Powder 210 gm Can</td><td>57.99USD</td><td>can</td></tr><tr><td>Cholestyramine resin powder</td><td>16.83USD</td><td>g</td></tr><tr><td>Questran 4 gm Packets</td><td>4.4USD</td><td>packet</td></tr><tr><td>Questran light packet</td><td>4.25USD</td><td>each</td></tr><tr><td>Questran packet</td><td>4.23USD</td><td>each</td></tr><tr><td>Cholestyramine 4 gm Packets</td><td>3.5USD</td><td>packet</td></tr><tr><td>Cholestyramine Light 4 gm Packets</td><td>3.49USD</td><td>packet</td></tr><tr><td>Cholestyramine light packet</td><td>3.35USD</td><td>each</td></tr><tr><td>Prevalite packet</td><td>2.58USD</td><td>each</td></tr><tr><td>Pms-Cholestyramine Light 4 g Powder Packet</td><td>1.41USD</td><td>packet</td></tr><tr><td>Pms-Cholestyramine Regular 4 g Powder Packet</td><td>1.41USD</td><td>packet</td></tr></tbody></table><div class="alert alert-warning clearfix">DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.</div></td></tr><tr><th>Patents</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>water solubility</td><td>Insoluble</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></table></td></tr><tr><th>Predicted Properties</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Moh. S. Amer, Jack C. Gray, &#8220;Cholestyramine compositions and method for preparation thereof.&#8221; U.S. Patent US4895723, issued March, 1967.</p></span><a class="wishart-link-out" href="https://www.google.com/?tbm=pts#q=4895723&amp;tbm=pts" target="_blank">US4895723 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><th>General Reference</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA448974" target="_blank">PA448974 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drug Product Database</td><td><a class="wishart-link-out" href="http://205.193.93.51/dpdonline/searchRequest.do?din=890960" target="_blank">890960 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>RxList</td><td><a class="wishart-link-out" href="http://www.rxlist.com/cgi/generic/cholestyramine.htm" target="_blank">http://www.rxlist.com/cgi/generic/cholestyramine.htm <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drugs.com</td><td><a class="wishart-link-out" href="http://www.drugs.com/cdi/cholestyramine-powder.html" target="_blank">http://www.drugs.com/cdi/cholestyramine-powder.html <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Cholestyramine" target="_blank">Cholestyramine <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td>C10AC01<ul class="atc-drug-tree"><li><a href="/atc/C#C">C &#8212; CARDIOVASCULAR SYSTEM</a></li><li><a href="/atc/C10#C10">C10 &#8212; LIPID MODIFYING AGENTS</a></li><li><a href="/atc/C10A#C10A">C10A &#8212; LIPID MODIFYING AGENTS, PLAIN</a></li><li><a href="/atc/C10AC#C10AC">C10AC &#8212; Bile acid sequestrants</a></li></ul></td></tr><tr><th>AHFS Codes</th><td><ul><li>24:06.04</li></ul></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>MSDS</th><td><a href="/system/msds/DB01432.pdf?1265922745">show</a>(74.1 KB)</td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB01418">Acenocoumarol</a></td><td>The bile acid sequestrant, cholestyramine, may decrease the anticoagulant effect of acenocoumarol by decreasing its absorption.</td></tr><tr><td><a href="/drugs/DB01125">Anisindione</a></td><td>The bile acid sequestrant, cholestyramine, may decrease the anticoagulant effect of anisindione by decreasing its absorption.</td></tr><tr><td><a href="/drugs/DB01393">Bezafibrate</a></td><td>Bile acid sequestrants like cholestyramine may decrease the absorption of fibric acid derivatives like bezafibrate. Therapy modification should be considered. If concomitant therapy is used, separate doses by at least 2 hours to minimize this interaction. Fenofibric acid labeling recommends administration one hour prior to or 4-6 hours after a bile acid sequestrant.
</td></tr><tr><td><a href="/drugs/DB00880">Chlorothiazide</a></td><td>Bile acid sequestrants may decrease the absorption of thiazide diuretics such as chlorothiazide. The diuretic response is likewise decreased. Monitor for decreased therapeutic effects of thiazide diuretics if coadministered with a bile acid sequestrant. If these agents are used concomitantly, separate doses 2 or more hours to minimize the interaction. </td></tr><tr><td><a href="/drugs/DB00169">Cholecalciferol</a></td><td>Bile acid sequestrants such as cholestyramine may decrease the serum concentration of Vitamin D analogs such as cholecalciferol. More specifically, bile acid sequestrants may impair absorption of Vitamin D analogs. Avoid concomitant administration of vitamin D analogs and bile acid sequestrants. Monitor plasma calcium concentrations in patients receiving combined therapy with these agents. This is particularly important in patients receiving higher doses of a bile acid sequestant (i.e., 30 g/day or more of cholestyramine or equivalent) or in patients experiencing bile acid sequestrant-induced steatorrhea. Specific recommendations regarding the separation of administration of these agents are not defined; however, it would seem prudent to separate the administration of these agents by several hours to minimize the potential risk of interaction. Similar precautions do not apply to parenterally administered vitamin D analogs. </td></tr><tr><td><a href="/drugs/DB00266">Dicoumarol</a></td><td>The bile acid sequestrant, cholestyramine, may decrease the anticoagulant effect of dicumarol by decreasing its absorption.</td></tr><tr><td><a href="/drugs/DB00390">Digoxin</a></td><td>The resin decreases the effect of digoxin</td></tr><tr><td><a href="/drugs/DB00973">Ezetimibe</a></td><td>Cholestyramine may decrease the levels of ezetimibe.</td></tr><tr><td><a href="/drugs/DB01095">Fluvastatin</a></td><td>Increased/decreased effect according to spacing</td></tr><tr><td><a href="/drugs/DB00741">Hydrocortisone</a></td><td>Cholestyramine may decrease the effect of hydrocortisone.</td></tr><tr><td><a href="/drugs/DB00451">Levothyroxine</a></td><td>The resin, cholestyramine, decreases the absorption of the thyroid hormone, levothyroxine.</td></tr><tr><td><a href="/drugs/DB00279">Liothyronine</a></td><td>The resin, cholestyramine, decreases the absorption of the thyroid hormones, liothyronine.</td></tr><tr><td><a href="/drugs/DB01583">Liotrix</a></td><td>The resin, cholestyramine, decreases the absorption of the thyroid hormone, liotrix.</td></tr><tr><td><a href="/drugs/DB08827">Lomitapide</a></td><td>Bile acid sequestrants also used for treating high cholesterol may interfere with the absorption of oral medications, thus separate administration by 4 hours. </td></tr><tr><td><a href="/drugs/DB00563">Methotrexate</a></td><td>Decreased levels of methotrexate</td></tr><tr><td><a href="/drugs/DB00481">Raloxifene</a></td><td>The resin decreases the effect of raloxifene</td></tr><tr><td><a href="/drugs/DB00421">Spironolactone</a></td><td>Increased risk of acidosis and hyperkalemia</td></tr><tr><td><a href="/drugs/DB00605">Sulindac</a></td><td>The bile acid sequestrant, cholestyramine, may decrease the absorption of the NSAID, sulindac. Monitor for changes in the therapeutic and adverse effects of sulindac if cholestyramine is initiated, discontinued or dose changed. Administering the two agents 2 or more hours apart may reduce, but not eliminate, the risk of this interactions.</td></tr><tr><td><a href="/drugs/DB00469">Tenoxicam</a></td><td>Cholestyramine may decrease the serum concentration of Tenoxicam by increasing clearance. Monitor for changes in Tenoxicam therapeutic and adverse effects if Cholestyramine is initiated, discontinued or dose changed. </td></tr><tr><td><a href="/drugs/DB01584">Thyroglobulin</a></td><td>The resin, cholestyramine, decreases the absorption of the thyroid hormone, thyroglobulin.</td></tr><tr><td><a href="/drugs/DB01600">Tiaprofenic acid</a></td><td>The bile acid sequestrant, Cholestyramine resin, may reduce Tiaprofenic acid absorption and therapeutic effect.</td></tr><tr><td><a href="/drugs/DB00500">Tolmetin</a></td><td>Cholestyramine may decrease the absorption of Tolmetin. Monitor for changes in the therapeutic and adverse effects of Tolmetin if Cholestyramine is initiated, discontinued or dose changed. Spacing administration by at least 2 hours may reduce the risk of interaction. </td></tr><tr><td><a href="/drugs/DB00214">Torasemide</a></td><td>Cholestyramine may decrease the bioavailability of Torasemide by inhibiting Torasemide absorption. Monitor for changes in the therapeutic and adverse effects of Torasemide if Cholestyramine is initiated, discontinued or dose changed. Spacing administration by at least 2 hours may reduce the risk of interaction.</td></tr><tr><td><a href="/drugs/DB01021">Trichlormethiazide</a></td><td>The bile acid sequestrant, Cholestyramine resin, may inhibit the absorption of Trichlormethiazide.</td></tr><tr><td><a href="/drugs/DB00197">Troglitazone</a></td><td>Decreases the effect of troglitazone</td></tr><tr><td><a href="/drugs/DB01586">Ursodeoxycholic acid</a></td><td>The resin decreases the effect of ursodiol</td></tr><tr><td><a href="/drugs/DB00682">Warfarin</a></td><td>The bile acid sequestrant, cholestyramine, may decrease the anticoagulant effect of warfarin by decreasing its absorption.</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Take with food, do not mix with soft drinks.</li></ul></td></tr></tbody></table>